ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Emselex 15 mg, Retardtabletten - 14 Tablette(n)
56871017 CPS Cito Pharma Services GmbH
Emselex 15 mg, Retardtabletten07.09.2005
  22.06.2006
Darifenacin (G04BD10)22.06.2006
WHO-DDD 
05.02.14 Tablette(n)
05.02. 
B  
Yes 
IPCI
10.20No
    
10 %27.50
7680568710172Synthetika
3305616● 
Composition
darifenacinum 15 mg ut darifenacini hydrobromidum, calcii hydrogenophosphas dihydricus, hypromellosum, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto.
Teilbarkeit
 Nein 
 Nein 
 Nein 
 -- 
 Verlust der Retardwirkung 
 
 
th_part
Delayed release tablets 
 
Active AgentDose
Darifenacin15 mg
BAG: Active AgentDose
Darifenacin15 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Rubrum)  
Calcium Hydrogen Phosphate Dihydrate  
E 171 color.
E 172 color.
Hypromellosum Überzug
Macrogol4000  
Magnesii Stearas  
Pro Compresso Obducto  
Talcum  
 
Source
Data was imported : 03.02.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home